During the past decade, IVI Valencia conducted 21 clinical trials. In the 10-year time frame, 21 clinical trials started and 3 clinical trials were completed, i.e. on average, 14.3% percent of trials that started reached the finish line to date. In the past 5 years, 7 clinical trials started and 2 clinical trials were completed. i.e. 28.6% of trials that started reached the finish line.

Out of the total clinical trials conducted in "IVI Valencia" #1 sponsor was "Instituto Valenciano de Infertilidad, IVI VALENCIA" with 37 trials, followed by "Igenomix" with 9 trials sponsored, "Ferring Pharmaceuticals" with 4 trials sponsored, "Fundación IVI" with 1 trials sponsored and "IVI Sevilla" with 1 trials sponsored. Other sponsors include -4 different institutions and companies that sponsored additional 6 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "IVI Valencia" #1 collaborator was "IVI Barcelona" with 4 trials as a collaborator, "IVI Madrid" with 4 trials as a collaborator, "IVI Bilbao" with 3 trials as a collaborator, "IVI Sevilla" with 2 trials as a collaborator and "IVI Vigo" with 2 trials as a collaborator. Other collaborators include 7 different institutions and companies that were collaborators in the rest 15 trials.

According to Clinical.Site data, the most researched conditions in "IVI Valencia" are "Infertility" (18 trials), "Infertility, Female" (5 trials), "Endometrial Receptivity" (2 trials), "Ovarian Stimulation" (2 trials) and "Pregnancy" (2 trials). Many other conditions were trialed in "IVI Valencia" in a lesser frequency.

Most popular intervention types in "IVI Valencia" are "Drug" (17 trials), "Other" (15 trials), "Procedure" (12 trials), "Diagnostic Test" (3 trials) and "Device" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (3 trials), "Endometrial fluid collection" (2 trials), "endometrial biopsy" (2 trials), "Agonist GnRH Acetate Triptoreline" (1 trials) and "Agonist GnRH; estradiol Valerate; progesterone" (1 trials). Other intervention names were less common.

The vast majority of trials in "IVI Valencia" are 49 trials for "Female" genders, 2 trials for "All" genders and 2 trials for "Male" genders.

Currently, there are NaN active trials in "IVI Valencia". undefined are not yet recruiting, 3 are recruiting, 3 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 37 completed trials in IVI Valencia, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in IVI Valencia, 0 "Phase 1" clinical trials were conducted, 4 "Phase 2" clinical trials and 7 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 8 trials, and there were also 21 trials that are defined as “Not Applicable".